Compare Kinder Morgan Inc (KMI) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs ResMed Inc. — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: Kinder Morgan Inc is far larger — about 2.5× ResMed Inc.'s market cap, and Kinder Morgan Inc pays the higher dividend (3.61%). Which is the better fit depends on your goals.
| KMI | RMD | |
|---|---|---|
Market Cap | $72.48B | $28.81B |
Sector | Energy | Health |
52-Week High | $34.31 | $293.73 |
52-Week Low | $25.84 | $182.82 |
Enterprise Value | $104.36B | $27.99B |
Dividend Yield | 3.61% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.38, up 0.25% for the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 2026 earnings, beating estimates with EPS of $0.48 versus $0.3959 expected, and revenue growth of 13.8% year-over-year. Analyst sentiment is mixed with 47% buy ratings, while the stock offers a dividend yield supported by stable cash flows from fee-based contracts.
KMI's outlook is supported by a $10.1 billion project backlog focused on natural gas infrastructure, rising LNG exports, and power demand. Risks include exposure to energy commodity volatility and high debt levels. The stock presents a value opportunity for income investors seeking stable dividends, but requires monitoring of execution on growth projects and energy market conditions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
